Based on announcements in early 2026, the FDA and HHS signaled reclassifying a group of peptides, including BPC-157, TB-500, and injectable GHK-Cu, toward Category 1, which makes them eligible for use by licensed compounding pharmacies preparing individualized medications under a prescription
Read our full article to understand the changes, key timelines, and what they mean for your labeling strategy: #FoodLabeling #FDA #Compliance #EurofinsFoodAssurance #FoodIndustry #Labeling To view or add a comment, sign in The $70 Billion Problem Nobody's Talking About I just released my interview with Jordan Glenn, Head of Science at SuppCo, and what he revealed about the supplement industry is deeply concerning
It is sterile water that contains a small amount of benzyl alcohol, usually 0.9%
If youre struggling with depression, dont be afraid to reach out to your primary care provider